Almac has launched Biomarkers for biopharma, a range of solutions to support biopharma companies in adopting biomarker strategies to help them better understand their drugs, improve success rates and values, and maximize the drugs’ potentials. The biomarker services include pharmacodynamic solutions, patient selection markers, assay development and bioinformatics/biostatistics consultancy. President and managing director of Almac’s Diagnostics division, Professor Paul Harkin, said, “With Biom...